Network Overview
Pharmatech Oncology has one of the largest oncology networks in the United States with nearly 1,200 investigators throughout 250 sites. Approximately 70% of the sites are research-oriented community-based sites, while the remaining are hospitals, institutions and VA Hospitals. Pharmatech manages the majority of the regulatory documents for its network members to mitigate the administrative burden on the investigators and permit them to focus on patient care. These documents include up-to-date Master Research Agreements, Master Confidentiality Agreements, Licenses, CV's, Site Profiles/Demographics, etc on file for each of its sites.
Pharmatech Oncology Announces Completion of SBIR Grant Research
10/19/2011
Pharmatech Oncology Announces ASH Abstract
10/11/2010
Press Release from Tamir Biotechnologies
7/6/2010
Pharmatech Oncology's Presentation at 46th Annual DIA Meeting
6/25/2010
Pharmatech Oncology to Present at 46th Annual DIA Meeting
6/10/2010
